Central pontine myelinolysis overview: Difference between revisions

Jump to navigation Jump to search
Prashanthsaddala (talk | contribs)
Created page with "__NOTOC__ {{Central pontine myelinolysis}} {{CMG}} ==Overview== '''Central pontine myelinolysis''' is a neurologic disease caused by severe damage of the myelin sheath of ..."
 
Charmaine Patel (talk | contribs)
No edit summary
Line 4: Line 4:
==Overview==
==Overview==
'''Central pontine myelinolysis''' is a neurologic disease caused by severe damage of the [[myelin sheath]] of [[neuron|nerve cells]] in the [[brainstem]], more precisely in the area termed the ''[[pons]]''.  It is a complication of treatment of patients with profound, life threatening [[hyponatraemia]]. It occurs as a consequence of a rapid rise in serum tonicity following treatment in individuals with chronic severe hyponatraemia who have made intracellular adaptations to the prevailing hypotonicity. It can also occur as a complication of correcting [[hypernatremia]] too rapidly.
'''Central pontine myelinolysis''' is a neurologic disease caused by severe damage of the [[myelin sheath]] of [[neuron|nerve cells]] in the [[brainstem]], more precisely in the area termed the ''[[pons]]''.  It is a complication of treatment of patients with profound, life threatening [[hyponatraemia]]. It occurs as a consequence of a rapid rise in serum tonicity following treatment in individuals with chronic severe hyponatraemia who have made intracellular adaptations to the prevailing hypotonicity. It can also occur as a complication of correcting [[hypernatremia]] too rapidly.
==Pathophysiology==
Rapid correction of [[hypernatremia]] causes water to move into cells, leading to multiple cerebral hemorrhages, equally catastrophic as osmotic demyelination.
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 20:45, 3 December 2012

Central pontine myelinolysis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Central pontine myelinolysis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Central pontine myelinolysis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Central pontine myelinolysis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Central pontine myelinolysis overview

CDC on Central pontine myelinolysis overview

Central pontine myelinolysis overview in the news

Blogs on Central pontine myelinolysis overview

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Central pontine myelinolysis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Central pontine myelinolysis is a neurologic disease caused by severe damage of the myelin sheath of nerve cells in the brainstem, more precisely in the area termed the pons. It is a complication of treatment of patients with profound, life threatening hyponatraemia. It occurs as a consequence of a rapid rise in serum tonicity following treatment in individuals with chronic severe hyponatraemia who have made intracellular adaptations to the prevailing hypotonicity. It can also occur as a complication of correcting hypernatremia too rapidly.

Pathophysiology

Rapid correction of hypernatremia causes water to move into cells, leading to multiple cerebral hemorrhages, equally catastrophic as osmotic demyelination.

References


Template:WikiDoc Sources